Understanding your genetic predispositions helps prescribers personalize dosing, medication selection, and adjunctive strategies tailored to your biology
For example, the FLOW trial demonstrated that GLP-1 medications can slow CKD progression and lower the risk of kidney failure
Suchankova P, Yan J, Schwandt ML, Stangl BL, Caparelli EC, Momenan R et al (2015)
These include: Nausea and vomiting Diarrhea or constipation Abdominal pain and bloating Acid reflux These symptoms are often most severe in the 24 to 48 hours following an injection when the medication concentration is at its highest
Hospital Universitario del Valle, Cali
Avexitide is designed to bind to the GLP-1 receptor on pancreatic islet beta cells and inhibit the effect of GLP-1 to mitigate hypoglycemia by decreasing insulin secretion and stabilizing blood glucose levels